130 related articles for article (PubMed ID: 19296441)
1. O-acetylated sialic acids: multifaceted role in childhood acute lymphoblastic leukaemia.
Chowdhury S; Mandal C
Biotechnol J; 2009 Mar; 4(3):361-74. PubMed ID: 19296441
[TBL] [Abstract][Full Text] [Related]
2. O-acetylation of GD3 prevents its apoptotic effect and promotes survival of lymphoblasts in childhood acute lymphoblastic leukaemia.
Mukherjee K; Chava AK; Mandal C; Dey SN; Kniep B; Chandra S; Mandal C
J Cell Biochem; 2008 Oct; 105(3):724-34. PubMed ID: 18655184
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of differential expression of sialic acids and adhesion molecules on mononuclear cells of bone marrow and peripheral blood in childhood acute lymphoblastic leukaemia at diagnosis and clinical remission.
Chowdhury S; Bandyopadhyay S; Chandra S; Mandal C
Indian J Biochem Biophys; 2007 Oct; 44(5):357-65. PubMed ID: 18341211
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of 9-O-acetylated sialoglycoproteins from leukemic cells and their potential as immunological tool for monitoring childhood acute lymphoblastic leukemia.
Pal S; Ghosh S; Mandal C; Kohla G; Brossmer R; Isecke R; Merling A; Schauer R; Schwartz-Albiez R; Bhattacharya DK; Mandal C
Glycobiology; 2004 Oct; 14(10):859-70. PubMed ID: 15190007
[TBL] [Abstract][Full Text] [Related]
5. Comparison of minimal residual disease (MRD) estimated by flow cytometry and by real-time quantitative PCR of Wilms tumor gene 1 (WT1) transcript expression in children with acute lymphoblastic leukemia.
Chen JS; Hsiao CC; Sheen JM; Cheng CN
Leuk Res; 2007 Oct; 31(10):1351-7. PubMed ID: 17445885
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against 9-O-acetylated sialic acids in childhood acute lymphoblastic leukemia: a two-year study with 186 samples following protocol MCP 943.
Bandyopadhyay S; Chatterjee M; Banavali SD; Pal S; Nair CN; Advani SH; Mandal C
Indian J Biochem Biophys; 2006 Feb; 43(1):7-14. PubMed ID: 16955745
[TBL] [Abstract][Full Text] [Related]
7. Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches.
Ryan J; Quinn F; Meunier A; Boublikova L; Crampe M; Tewari P; O'Marcaigh A; Stallings R; Neat M; O'Meara A; Breatnach F; McCann S; Browne P; Smith O; Lawler M
Br J Haematol; 2009 Jan; 144(1):107-15. PubMed ID: 19016726
[TBL] [Abstract][Full Text] [Related]
8. Regulation of O-acetylation of sialic acids by sialate-O-acetyltransferase and sialate-O-acetylesterase activities in childhood acute lymphoblastic leukemia.
Mandal C; Mandal C; Chandra S; Schauer R; Mandal C
Glycobiology; 2012 Jan; 22(1):70-83. PubMed ID: 21803834
[TBL] [Abstract][Full Text] [Related]
9. Mobilization of lymphoblasts from bone marrow to peripheral blood in childhood acute lymphoblastic leukaemia: role of 9-O-acetylated sialoglycoproteins.
Chowdhury S; Mandal C; Sarkar S; Bag AK; Vlasak R; Chandra S; Mandal C
Leuk Res; 2012 Feb; 36(2):146-55. PubMed ID: 22078066
[TBL] [Abstract][Full Text] [Related]
10. Interferon gamma promotes survival of lymphoblasts overexpressing 9-O-acetylated sialoglycoconjugates in childhood acute lymphoblastic leukaemia (ALL).
Ghosh S; Bandyopadhyay S; Mallick A; Pal S; Vlasak R; Bhattacharya DK; Mandal C
J Cell Biochem; 2005 May; 95(1):206-16. PubMed ID: 15770663
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of 9-O-acetylated sialoglycoproteins and their binding proteins on lymphoblasts of childhood acute lymphoblastic leukemia: an anti-apoptotic role.
Mukherjee K; Chava AK; Bandyopadhyay S; Mallick A; Chandra S; Mandal C
Biol Chem; 2009 Apr; 390(4):325-35. PubMed ID: 19166321
[TBL] [Abstract][Full Text] [Related]
12. Flow-cytometric monitoring of disease-associated expression of 9-O-acetylated sialoglycoproteins in combination with known CD antigens, as an index for MRD in children with acute lymphoblastic leukaemia: a two-year longitudinal follow-up study.
Chowdhury S; Bandyopadhyay S; Mandal C; Chandra S; Mandal C
BMC Cancer; 2008 Feb; 8():40. PubMed ID: 18241334
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
14. Over-expressed IgG2 antibodies against O-acetylated sialoglycoconjugates incapable of proper effector functioning in childhood acute lymphoblastic leukemia.
Bandyopadhyay S; Bhattacharyya A; Mallick A; Sen AK; Tripathi G; Das T; Sa G; Bhattacharya DK; Mandal C
Int Immunol; 2005 Feb; 17(2):177-91. PubMed ID: 15629900
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia.
Sutton R; Venn NC; Tolisano J; Bahar AY; Giles JE; Ashton LJ; Teague L; Rigutto G; Waters K; Marshall GM; Haber M; Norris MD;
Br J Haematol; 2009 Aug; 146(3):292-9. PubMed ID: 19500099
[TBL] [Abstract][Full Text] [Related]
16. Detection of immune-complexed 9-O-acetylated sialoglycoconjugates in the sera of patients with pediatric acute lymphoblastic leukemia.
Bandyopadhyay S; Mukherjee K; Chatterjee M; Bhattacharya DK; Mandal C
J Immunol Methods; 2005 Feb; 297(1-2):13-26. PubMed ID: 15777927
[TBL] [Abstract][Full Text] [Related]
17. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.
Basso G; Veltroni M; Valsecchi MG; Dworzak MN; Ratei R; Silvestri D; Benetello A; Buldini B; Maglia O; Masera G; Conter V; Arico M; Biondi A; Gaipa G
J Clin Oncol; 2009 Nov; 27(31):5168-74. PubMed ID: 19805690
[TBL] [Abstract][Full Text] [Related]
18. Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now.
Goulden N; Virgo P; Grimwade D
Br J Haematol; 2006 Aug; 134(3):273-82. PubMed ID: 16848770
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of 9-O-acetylated sialoglycoconjugates on leukemic blasts: a potential tool for long-term monitoring of children with acute lymphoblastic leukemia.
Pal S; Ghosh S; Bandyopadhyay S; Mandal C; Bandhyopadhyay S; Kumar Bhattacharya D; Mandal C
Int J Cancer; 2004 Aug; 111(2):270-7. PubMed ID: 15197782
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against 9-O-acetylated sialoglycans: a potent marker to monitor clinical status in childhood acute lymphoblastic leukemia.
Pal S; Bandyopadhyay S; Chatterjee M; Bhattacharya DK; Minto L; Hall AG; Mandal C
Clin Biochem; 2004 May; 37(5):395-403. PubMed ID: 15087256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
